Immunotherapy - risk/benefit in food allergy

Pediatric Allergy and Immunology

Volumn 24, Issue 7, 2013, Pages 633-644

  Kostadinova, Atanaska I ^a,b   Willemsen, Linette E M ^a   Knippels, Léon M J ^a,b   Garssen, Johan ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Nutricia Nederland   (Netherlands)

Author keywords

Cow's milk allergy; Desensitization; Food allergy; Immunotherapy; Oral tolerance; Peanut allergy; Tolerogenic peptides

Indexed keywords

ANTIGEN; FOOD ALLERGEN; IMMUNOGLOBULIN E; MILK PROTEIN; PEPTIDE; PLACEBO;

ALLERGIC REACTION; AVOIDANCE BEHAVIOR; DESENSITIZATION; EPICUTANEOUS IMMUNOTHERAPY; HEALTH CARE QUALITY; HUMAN; IMMUNOTHERAPY; MEMORY T LYMPHOCYTE; MILK; MILK ALLERGY; ORAL IMMUNOTHERAPY; PEANUT; PEANUT ALLERGY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN INTAKE; REVIEW; RISK BENEFIT ANALYSIS; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

COW'S MILK ALLERGY; DESENSITIZATION; FOOD ALLERGY; IMMUNOTHERAPY; ORAL TOLERANCE; PEANUT ALLERGY; TOLEROGENIC PEPTIDES;

ALLERGENS; ANIMALS; CLINICAL PROTOCOLS; DESENSITIZATION, IMMUNOLOGIC; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE; PEPTIDE FRAGMENTS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84885713488     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12122     Document Type: Review

References (95)

1. Sicherer SH, Sampson HA. Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2009: 60: 261-77.
2. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics 2009: 124: 1549-55.
3. Prescott S, Allen KJ. Food allergy: riding the second wave of the allergy epidemic. Pediatr Allergy Immunol 2011: 22: 155-60.
4. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007: 62: 91-6.
5. Lee LA, Burks AW. Food allergies: prevalence, molecular characterization, and treatment/prevention strategies. Annu Rev Nutr 2006: 26: 539-65.
6. Vickery BP, Chin S, Burks AW. Pathophysiology of food allergy. Pediatr Clin North Am 2011: 58: 363-76, ix-x.
7. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001: 107: 191-3.
8. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007: 119: 1016-8.
9. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics 2003: 111: 1601-8.
10. Vickery BP, Scurlock AM, Jones SM, Burks AW. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol 2011: 127: 576-84; quiz 85-6.
11. Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001: 87: 461-4.
12. Santos AF, Lack G. Food allergy and anaphylaxis in pediatrics: update 2010-2012. Pediatr Allergy Immunol 2012: 23: 698-706.
13. Ozdemir C. An immunological overview of allergen specific immunotherapy - subcutaneous and sublingual routes. Ther Adv Respir Dis 2009: 3: 253-62.
14. Akdis CA. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 2012: 18: 736-49.
15. Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2005: 115: 676-84.
16. Frati F, Incorvaia C, Lombardi C, Senna G. Allergen immunotherapy: 100 years, but it does not look like. Eur Ann Allergy Clin Immunol 2012: 44: 99-106.
17. Berin MC, Sicherer S. Food allergy: mechanisms and therapeutics. Curr Opin Immunol 2011: 23: 794-800.
18. Fisher HR, du Toit G, Lack G. Specific oral tolerance induction in food allergic children: is oral desensitisation more effective than allergen avoidance?: a meta-analysis of published RCTs. Arch Dis Child 2011: 96: 259-64.
19. Brozek JL, Terracciano L, Hsu J, et al. Oral immunotherapy for IgE-mediated cow's milk allergy: a systematic review and meta-analysis. Clin Exp Allergy 2012: 42: 363-74.
20. Yeung JP, Kloda LA, McDevitt J, Ben-Shoshan M, Alizadehfar R. Oral immunotherapy for milk allergy. Cochrane Database Syst Rev 2012: 11: CD009542.
21. Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012: 9: CD009014.
22. Calderon MA, Gerth van Wijk R, Eichler I, et al. Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol 2012: 23: 300-6.
23. Chase MW. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 1946: 61: 257-9.
24. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005: 115: 3-12; quiz 13.
25. Dello Iacono I, Verga MC. Sudden loss of cow's milk tolerance in a long-sensitized patient. Eur Ann Allergy Clin Immunol 2012: 44: 172-4.
26. van Wijk F, Knippels L. Initiating mechanisms of food allergy: oral tolerance versus allergic sensitization. Biomed Pharmacother 2007: 61: 8-20.
27. Fujita H, Soyka MB, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy 2012: 2: 2.
28. Mousallem T, Burks AW. Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy. Clin Exp Immunol 2012: 167: 26-31.
29. Groetch M, Nowak-Wegrzyn A. Practical approach to nutrition and dietary intervention in pediatric food allergy. Pediatr Allergy Immunol 2013: 24: 212-21.
30. Flammarion S, Santos C, Guimber D, et al. Diet and nutritional status of children with food allergies. Pediatr Allergy Immunol 2011: 22: 161-5.
31. Diamanti A, Pedicelli S, D'Argenio P, Panetta F, Alterio A, Torre G. Iatrogenic Kwashiorkor in three infants on a diet of rice beverages. Pediatr Allergy Immunol 2011: 22: 878-9.
32. Larenas-Linnemann D. Certainties and doubts about sublingual and oral immunotherapy in children. Curr Opin Allergy Clin Immunol 2009: 9: 558-67.
33. Nowak-Wegrzyn A, Fiocchi A. Is oral immunotherapy the cure for food allergies? Curr Opin Allergy Clin Immunol 2010: 10: 214-9.
34. Rachid R, Umetsu DT. Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol 2012: 34: 689-702.
35. Fuentes-Aparicio V, Alonso-Lebrero E, Zapatero L, et al. Oral immunotherapy in hen's egg-allergic children increases a hypo-proliferative subset of CD4+ T cells that could constitute a marker of tolerance achievement. Pediatr Allergy Immunol 2012: 23: 648-53.
36. Rolinck-Werninghaus C, Staden U, Mehl A, Hamelmann E, Beyer K, Niggemann B. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy? Allergy 2005: 60: 1320-2.
37. Henson M, Burks AW. The future of food allergy therapeutics. Semin Immunopathol 2012: 34: 703-14.
38. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992: 90: 256-62.
39. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997: 99: 744-51.
40. Nowak-Wegrzyn A, Sampson HA. Future therapies for food allergies. J Allergy Clin Immunol 2011: 127: 558-73; quiz 74-5.
41. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004: 59: 980-7.
42. Salmivesi S, Korppi M, Makela MJ, Paassilta M. Milk oral immunotherapy is effective in school-aged children. Acta Paediatr 2013: 102: 172-6.
43. Skripak JM, Nash SD, Rowley H, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008: 122: 1154-60.
44. Bauer A, Ekanayake Mudiyanselage S, Wigger-Alberti W, Elsner P. Oral rush desensitization to milk. Allergy 1999: 54: 894-5.
45. Patriarca G, Nucera E, Pollastrini E, et al. Oral rush desensitization in peanut allergy: a case report. Dig Dis Sci 2006: 51: 471-3.
46. Staden U, Blumchen K, Blankenstein N, et al. Rush oral immunotherapy in children with persistent cow's milk allergy. J Allergy Clin Immunol 2008: 122: 418-9.
47. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008: 121: 343-7.
48. Barbi E, Longo G, Berti I, et al. Adverse effects during specific oral tolerance induction: in-hospital "rush" phase. Eur Ann Allergy Clin Immunol 2012: 44: 18-25.
49. Pajno GB, Caminiti L, Salzano G, et al. Comparison between two maintenance feeding regimens after successful cow's milk oral desensitization. Pediatr Allergy Immunol 2013: 24: 376-81.
50. Patriarca C, Romano A, Venuti A, et al. Oral specific hyposensitization in the management of patients allergic to food. Allergol Immunopathol (Madr) 1984: 12: 275-81.
51. Patriarca G, Schiavino D, Nucera E, Schinco G, Milani A, Gasbarrini GB. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998: 45: 52-8.
52. Patriarca G, Nucera E, Roncallo C, et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003: 17: 459-65.
53. Meglio P, Giampietro P, Gianni S, Galli E. Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy-follow-up at 4 yr and 8 months. Pediatr Allergy Immunol 2008: 19: 412-9.
54. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007: 62: 1261-9.
55. MacDonald TT, Di Sabatino A. The immunologic basis for gastrointestinal food allergy. Curr Opin Gastroenterol 2009: 25: 521-6.
56. Martorell A, De la Hoz B, Ibanez MD, et al. Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy 2011: 41: 1297-304.
57. Longo G, Berti I, Barbi E, et al. Diagnosed child, treated child: food challenge as the first step toward tolerance induction in cow's milk protein allergy. Eur Ann Allergy Clin Immunol 2012: 44: 54-60.
58. Pajno GB, Caminiti L, Ruggeri P, et al. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010: 105: 376-81.
59. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy 2009: 64: 1218-20.
60. Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009: 124: 292-300, 00 e1-97.
61. Hofmann AM, Scurlock AM, Jones SM, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009: 124: 286-91, 91 e1-6.
62. Varshney P, Steele PH, Vickery BP, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009: 124: 1351-2.
63. Varshney P, Jones SM, Pons L. Peanut oral immunotherapy (OIT) induces immunologic changes supporting the development of tolerance. J Allergy Clin Immunol 2010: 125: AB59.
64. Blumchen K, Ulbricht H, Staden U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010: 126: 83-91 e1.
65. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011: 127: 654-60.
66. Senna GE, Calderon M, Milani M. Allergy immunotherapy tablet: Grazax(R) for the treatment of grass pollen allergy. Expert Rev Clin Immunol 2011: 7: 21-7.
67. Mempel M, Rakoski J, Ring J, Ollert M. Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 2003: 111: 1406-9.
68. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005: 116: 1073-9.
69. Fernandez-Rivas M, Garrido Fernandez S, Nadal JA, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009: 64: 876-83.
70. Narisety SD, Keet CA. Sublingual vs oral immunotherapy for food allergy: identifying the right approach. Drugs 2012: 72: 1977-89.
71. de Boissieu D, Dupont C. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy 2006: 61: 1238-9.
72. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012: 129: 448-55, 55 e1-5.
73. Kim EH, Bird JA, Kulis M, et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011: 127: 640-6 e1.
74. Fleischer DM, Burks AW, Vickery BP, et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013: 131: 119-27 e1-7.
75. Chin SJ, Vickery BP, Kulis MD, et al. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol 2013: 132: 476-78 e2.
76. Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma 2009: 46: 322-34.
77. Mondoulet L, Dioszeghy V, Ligouis M, Dhelft V, Dupont C, Benhamou PH. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy 2010: 40: 659-67.
78. Mondoulet L, Dioszeghy V, Vanoirbeek JA, Nemery B, Dupont C, Benhamou PH. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol 2011: 154: 299-309.
79. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010: 125: 1165-7.
80. Otsu K, Fleischer DM. Therapeutics in food allergy: the current state of the art. Curr Allergy Asthma Rep 2012: 12: 48-54.
81. Mitragotri S. Immunization without needles. Nat Rev Immunol 2005: 5: 905-16.
82. Sparber F, Tripp CH, Hermann M, Romani N, Stoitzner P. Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin. Immunobiology 2010: 215: 770-9.
83. Knipping K, van Esch BC, van Ieperen-van Dijk AG, et al. Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE-mediated mast cell activation compared to T-cell activation. Int Arch Allergy Immunol 2012: 159: 263-70.
84. Larche M. Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches. Pharmacol Ther 2005: 108: 353-61.
85. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc Natl Acad Sci U S A 1993: 90: 7608-12.
86. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993: 178: 1783-8.
87. Astori M, von Garnier C, Kettner A, Dufour N, Corradin G, Spertini F. Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J Immunol 2000: 165: 3497-505.
88. Moldaver D, Larche M. Immunotherapy with peptides. Allergy 2011: 66: 784-91.
89. Yang M, Yang C, Mine Y. Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms. Clin Exp Allergy 2010: 40: 668-78.
90. Inoue R, Matsushita S, Kaneko H, et al. Identification of beta-lactoglobulin-derived peptides and class II HLA molecules recognized by T cells from patients with milk allergy. Clin Exp Allergy 2001: 31: 1126-34.
91. Hirahara K, Hisatsune T, Choi CY, Kaminogawa S. Profound immunological tolerance in the antibody response against bovine alpha s1-casein induced by intradermal administration of a dominant T cell determinant. Clin Immunol Immunopathol 1995: 76: 12-8.
92. Pecquet S, Bovetto L, Maynard F, Fritsche R. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice. J Allergy Clin Immunol 2000: 105: 514-21.
93. van Esch BC, Schouten B, de Kivit S, et al. Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3+ regulatory T-cells in the mesenteric lymph nodes. Pediatr Allergy Immunol 2011: 22: 820-6.
94. Campbell JD, Buckland KF, McMillan SJ, et al. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009: 206: 1535-47.
95. Meulenbroek LA, van Esch BC, Hofman GA, et al. Oral treatment with beta-lactoglobulin peptides prevents clinical symptoms in a mouse model for cow's milk allergy. Pediatr Allergy Immunol 2013: Sep 12. doi: 10.1111/pai.12120.